Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Medullary thyroid carcinoma as a disease reference. Included the Genetic and Rare Diseases Information Center as a Resources entry.
    Difference
    0.2%
    Check dated 2026-04-03T05:15:53.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T19:19:55.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T10:54:23.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and prior government-funding notices as well as Revision: v3.4.1 were removed. This change does not affect study content, eligibility criteria, or results.
    Difference
    0.5%
    Check dated 2026-02-11T21:08:30.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the page version updated from v3.4.0 to v3.4.1. No study details, inclusion criteria, or outcome measures were changed.
    Difference
    0.5%
    Check dated 2026-02-04T10:58:51.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Adds a glossary toggle and updates metadata labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with the revision tag changed to v3.4.0 (from v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T06:32:40.000Z thumbnail image

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.